Rakuten Investment Management »

Alnylam Pharmaceuticals shares owned by Rakuten Investment Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Rakuten Investment Management from 13F filings

Historical chart of Rakuten Investment Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Rakuten Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Rakuten Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.6M 31k 211.28
2024-09-30 $636k 2.3k 274.91
2024-06-30 $430k 1.7k 247.00
2024-03-31 $162k 1.1k 149.45
2023-12-31 $18k 90 195.70

More positions owned by Rakuten Investment Management

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
O'reilly Automotive (ORLY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Applovin Corp Com Cl A (APP)
Monster Beverage Corp (MNST)
Brown Forman Corp CL B (BF.B)
Molina Healthcare (MOH)
Vanguard Whitehall Fds High Div Yld (VYM)
Alphabet Cap Stk Cl C (GOOG)
Travelers Companies (TRV)
Altria (MO)
Kkr & Co (KKR)

View all positions for Rakuten Investment Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals